Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$86.26 - $119.0 $1.75 Million - $2.42 Million
-20,322 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$100.17 - $126.36 $370,528 - $467,405
3,699 Added 22.25%
20,322 $2.27 Million
Q2 2021

Aug 13, 2021

BUY
$86.05 - $119.72 $1.43 Million - $1.99 Million
16,623 New
16,623 $1.89 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Klk Capital Management LLC Portfolio

Follow Klk Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klk Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klk Capital Management LLC with notifications on news.